Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
AssigneeHigh Point Pharmaceuticals, LLC
InventorsJohn Paul Kilburn, Henrik Sune Andersen, Gita Camilla Tejlgaard Kampen
Life of this patent
Estimating the term…
Loading patent…
AssigneeHigh Point Pharmaceuticals, LLC
InventorsJohn Paul Kilburn, Henrik Sune Andersen, Gita Camilla Tejlgaard Kampen
Estimating the term…
The use of substituted amides of structure (I) for modulating the activity of 11 β-hydroxysteroid dehydrogenase type 1 (11 βHSD1) and the use of these compounds as pharmaceutical compositions, are described. Also a novel class of substituted amides, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11 βHSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.
A compound of the formula I:
(canceled)
(canceled)
The method of claim 14, wherein the conditions, disorders and diseases are conditions, disorders and diseases that are influenced by intracellular glucocorticoid levels.
The method of claim 14, wherein the conditions, disorders or diseases are selected from the group consisting of the metabolic syndrome, insulin resistance, dyslipidemia, hypertension and obesity.
Dependencies are inferred from the claim text.